122 related articles for article (PubMed ID: 29789103)
1. Evaluation of Ion-pair Formation of Adefovir to Improve Permeation across Artificial and Biological Membranes.
Darsazan B; Shafaati A; Zarghi A; Mortazavi SA
J Pharm Pharm Sci; 2018; 21(1):160-170. PubMed ID: 29789103
[TBL] [Abstract][Full Text] [Related]
2. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.
Annaert P; Tukker JJ; van Gelder J; Naesens L; de Clercq E; van Den Mooter G; Kinget R; Augustijns P
J Pharm Sci; 2000 Aug; 89(8):1054-62. PubMed ID: 10906729
[TBL] [Abstract][Full Text] [Related]
3. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
4. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.
Ming X; Thakker DR
Biochem Pharmacol; 2010 Feb; 79(3):455-62. PubMed ID: 19735648
[TBL] [Abstract][Full Text] [Related]
5. Transdermal and dermal delivery of adefovir: effects of pH and permeation enhancers.
Vávrová K; Lorencová K; Klimentová J; Novotný J; Holý AN; Hrabálek A
Eur J Pharm Biopharm; 2008 Jun; 69(2):597-604. PubMed ID: 18248973
[TBL] [Abstract][Full Text] [Related]
6. Absorption enhancement of adefovir dipivoxil by incorporating MCT and ethyl oleate complex oil phase in emulsion.
Li P; Yu HZ; Zhang XX; Gan L; Zhu CL; Gan Y
Acta Pharmacol Sin; 2010 Jul; 31(7):881-8. PubMed ID: 20562905
[TBL] [Abstract][Full Text] [Related]
7. Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.
Reddy KR; Matelich MC; Ugarkar BG; Gómez-Galeno JE; DaRe J; Ollis K; Sun Z; Craigo W; Colby TJ; Fujitaki JM; Boyer SH; van Poelje PD; Erion MD
J Med Chem; 2008 Feb; 51(3):666-76. PubMed ID: 18173234
[TBL] [Abstract][Full Text] [Related]
8. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
9. Adefovir dipivoxil.
Noble S; Goa KL
Drugs; 1999 Sep; 58(3):479-87; discussion 488-9. PubMed ID: 10493275
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayers.
Annaert P; Gosselin G; Pompon A; Benzaria S; Valette G; Imbach JL; Naesens L; Hatse S; de Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1998 Feb; 15(2):239-45. PubMed ID: 9523310
[TBL] [Abstract][Full Text] [Related]
11. Enhancement and in vitro evaluation of amifostine permeation through artificial membrane (PAMPA) via ion pairing approach and mechanistic selection of its optimal counter ion.
Samiei N; Shafaati A; Zarghi A; Moghimi HR; Foroutan SM
Eur J Pharm Sci; 2014 Jan; 51():218-23. PubMed ID: 24161609
[TBL] [Abstract][Full Text] [Related]
12. Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cells.
Ray AS; Vela JE; Olson L; Fridland A
Biochem Pharmacol; 2004 Nov; 68(9):1825-31. PubMed ID: 15450948
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and safety of adefovir dipivoxil in children and adolescents with chronic hepatitis B virus infection.
Sokal EM; Kelly D; Wirth S; Mizerski J; Dhawan A; Frederick D
J Clin Pharmacol; 2008 Apr; 48(4):512-7. PubMed ID: 18276803
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of adefovir dipivoxil tablets in healthy Chinese volunteers.
Huang J; Zhang Y; Huang X; Li L; Li Y; Wang K; Yang J; He Y; Lv Y; Zheng Q
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):8-14. PubMed ID: 24219967
[TBL] [Abstract][Full Text] [Related]
15. Adefovir dipivoxil: a review of its use in chronic hepatitis B.
Dando T; Plosker G
Drugs; 2003; 63(20):2215-34. PubMed ID: 14498759
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1α,25-Dihydroxyvitamin D3 on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats.
Yoon IS; Son JH; Kim SB; Choi MK; Maeng HJ
Biol Pharm Bull; 2015; 38(11):1732-7. PubMed ID: 26521823
[TBL] [Abstract][Full Text] [Related]
18. Liquid oral suspension adefovir dipivoxil (GS-02-526): an update on treatments for hepatitis B infection.
Chen EQ; Shi Y; Wu DB; Tang H
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):919-28. PubMed ID: 24927815
[TBL] [Abstract][Full Text] [Related]
19. Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil.
Yuan LC; Dahl TC; Oliyai R
Pharm Res; 2000 Sep; 17(9):1098-103. PubMed ID: 11087042
[TBL] [Abstract][Full Text] [Related]
20. Pradefovir, a liver-targeted prodrug of adefovir against HBV infection.
Tillmann HL
Curr Opin Investig Drugs; 2007 Aug; 8(8):682-90. PubMed ID: 17668370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
